
Artemid supports Biotech Dental
The Artemid Senior Loan III fund is providing €20 million in financing that will enable the company to continue its international growth, particularly in the United States where the company has just acquired IDS, the last major independent distributor of dental implants.
Biotech Dental’s strategy is based on continuous innovation in both software and digital manufacturing processes.
This technological culture has enabled the group to build an offer of high quality products at affordable prices, 100% “Made in France”, in their manufacturing centers in the Arve Valley (Rhône-Alpes) and Salon-de-Provence, where its head office is also located.
The funds in the Artemid range are managed by the asset management company CAPZA as well as a third party portfolio management company and advised by Artemid SAS, a joint subsidiary of CAPZA and Amiral Gestion. Artemid SAS is a financial investment advisor (conseiller en investissement financier – CIF) registered at the ORIAS under the number 14003497 since 5/28/2014.
-
7May’ 2025CAPZA sells its minority stake in EduservicesCAPZA exits from Eduservices after supporting the group’s growth.Read more
-
5May’ 2025Artemid supports FGN’s growth strategyArtemid co-arranged the refinancing of the existing senior indebtedness to support FGN in its further growth.Read more
-
29Apr’ 2025CAPZA supports Rubicon’s next stage of growthCAPZA arranges a Unitranche financing to support IceLake's acquisition of Rubicon.Read more
-
16Apr’ 2025CAPZA supports the development of MecadaqCAPZA enters into exclusive negotiations to acquire a majority stake in Mecadaq, a strategic player in the civil and defense aerospace industry.Read more